Be Pharmaceuticals Private Limited, a active private limited company, was established on 29 August 2011 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2011PTC148362. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.01 Cr.
Formerly known as Akorn India Private Limited. It upholds a compliant status. Employing 3 professional, Its leadership includes Rudaraju Anand Kumar (Director), Mahipal Reddy Saddi (Director), Mahima Datla (Director). Past directors included Dheeraj Chopra, Nilesh Pravin Gandhi, Rudaraju Anand Kumar. It holds no open charges and ₹20.00 Cr settled loans. Its latest AGM occurred on 18 September 2024, with the balance sheet filed on 31 March 2024. It is based at 18/1 & 3, Azamabad,, Hyderabad, Telangana, 500020.
U24100TG2011PTC148362
148362
29 August 2011
₹6.00 Cr
₹5.01 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Be Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rudaraju Anand Kumar | Director | 14 Aug 2020 | Current |
| Mahipal Reddy Saddi | Director | 26 Aug 2020 | Current |
| Mahima Datla | Director | 14 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 14 Aug 2020 | Past |
| Pramod Abcsdd | Director | 28 Sep 2011 | Past |
| Pramod Abcsdd | Additional Director | 17 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 04 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 17 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 01 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Be Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.85% increase. The company also saw a substantial improvement in profitability, with a 381.89% increase in profit. The company's net worth moved up by a moderate rise of 3.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Be Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹200,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2014 | Icici Bank Limited | ₹20.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Be Pharmaceuticals has a workforce of 3 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Be Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Be Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Be Pharmaceuticals Private Limited last Annual general meeting of members was held on 18 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Be Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Mahipal Reddy Saddi was appointed as a Director was appointed as a Director on 26 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on Rudaraju Anand Kumar was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
Mahima Datla was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
A charge registered on 25 Jul 2014 via Charge ID 10522225 with Icici Bank Limited was fully satisfied on 29 Jan 2015. was recorded as a recent event.
When you thought you had a sweet deal but then the court said "nah fam, business is bad" and the CEO was like "aight, I'll step down." #RIPbuyout #DelawareSupremeCourt #FreseniusSE #AkornInc #genericdrugs.
The CIN of Be Pharmaceuticals Private Limited is U24100TG2011PTC148362.
Be Pharmaceuticals Private Limited is headquartered at 18/1 & 3, Azamabad,, Hyderabad, Telangana, 500020.
Be Pharmaceuticals Private Limited was incorporated on 29 August 2011.
The current directors of Be Pharmaceuticals Private Limited are
The primary industry of Be Pharmaceuticals Private Limited is Manufacturing.
Be Pharmaceuticals Private Limited is unlisted.
The authorized capital of Be Pharmaceuticals Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.01 Cr.
The compliance status of Be Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX